Kenneth Cardona, MD, FACS
-
RoleSurgical Oncology
-
Specialty
-
Research Program
-
Practicing Since2012
Background
Kenneth Cardona, MD, FACS is a board-certified surgeon and surgical oncologist who joined the Emory University faculty in 2012 after completing a Fellowship in Surgical Oncology at Memorial Sloan-Kettering Cancer Center in New York. Dr. Cardona has a clinical interest and expertise in the management of retroperitoneal/abdominal sarcomas as well as soft tissue sarcomas of the trunk and limbs. As a leader and active member of the Winship Sarcoma Disease Team, he collaborates with soft tissue pathologists, medical and radiation oncologists, and interventional radiologists with expertise in the treatment of sarcomas to develop individualized treatment plans for each patient.
Dr. Cardona leads national research efforts in the study of sarcoma as the Chair of the National Cancer Institute’s ECOG-ACRIN Sarcoma Committee. He is the Principal Investigator of various sarcoma clinical trials and collaborates with sarcoma clinicians from around the country on sarcoma research projects. Internationally, he is an active member of the multi-institutional TransAtlantic Retroperitoneal Sarcoma Working Group and Desmoid Working Group.
Dr. Cardona serves as Associate Chief Medical Officer for Winship Cancer Institute at Emory Midtown. In this role, he helps direct clinical operations related to oncologic services at the facility and related clinics.
Titles & Roles
-
Patricia R. Reynolds Professor in SarcomaEmory University School of Medicine
-
Professor, Division of Surgical Oncology, Department of SurgeryEmory University School of Medicine
-
Associate Chief Medical OfficerWinship Cancer Institute at Emory Midtown
-
Sarcoma Disease Team LeadWinship Cancer Institute of Emory University
Education & Training
Education
- Fellowship, Surgical Oncology, 2012Memorial Sloan-Kettering Cancer Center
- Residency, General Surgery, 2010Emory University School of Medicine
- Medical Education, MD, 2002Ponce School of Medicine
Board Certifications
- Surgery (General Surgery)American Board of Surgery, 2010
Professional Memberships
- Connective Tissue Oncology Society
- American Society of Clinical Oncology
- Society of Surgical Oncology
- Americas Hepato-Pancreato-Biliary Association
- American College of Surgeons
- Georgia Surgical Society
Research
Dr. Cardona's research interests are in clinical and outcomes investigations in patients with soft tissue sarcomas of the trunk, extremity or retroperitoneum. He is an active member of the TransAtlantic Retroperitoneal Sarcoma Working Group, a collaborative that involves sarcoma experts from over 40 centers across the world, he has been involved in numerous publications focusing on guidelines for management and treatment of patients with primary and recurrent retroperitoneal sarcomas.
-
- PhaseIII
-
ConditionsMetastatic Dedifferentiated Liposarcoma, Metastatic Undifferentiated Pleomorphic Sarcoma, Stage III Soft Tissue Sarcoma of the Trunk and Extremities AJCC v8, Stage IV Soft Tissue Sarcoma of the Trunk and Extremities AJCC v8, Unresectable Dedifferentiated Liposarcoma, Unresectable Undifferentiated Pleomorphic Sarcoma
- LocationEmory University Hospital Midtown
-
-
Surgery With or Without Neoadjuvant Chemotherapy in High Risk RetroPeritoneal Sarcoma
- PhaseIII
-
ConditionsRetroperitoneal Sarcoma, Liposarcoma, Leiomyosarcoma
- LocationEmory University Hospital Midtown
-
Publications
Dr. Cardona has numerous publications in peer-reviewed journals and is on the editorial board of the soft tissue sarcoma section of various high-impact journals including Annals of Surgical Oncology, Journal of Surgical Oncology and Oncology.
Awards
- Top Doctors, Atlanta Magazine, 2016, 2017, 2018
- Douglas Murray Academic Professionalism Award, Department of Surgery, Emory University, 2009
- Award of Academic Excellence, Department of Surgery, Emory University, 2008
- Young Scientist Award, Immune Tolerance Network, 2006
- Young Investigator Award, World Transplant Congress, 2006, 2007
- Young Investigator Award, International Pancreas & Islet Transplantation Association, 2005
- Luis F. Sala, MD, Distinguished Graduate Award, 2002
Ratings & Reviews
Patients who are treated in outpatient and inpatient environments are eligible to receive a survey related to their individual care. Displayed ratings and reviews are displayed for Providers who have received at least 30 returned surveys over a 12-month period and are related to all Care Provider related survey questions. To help our patients better understand our Transparency program (ratings and review), the motivations behind it, how ratings are calculated, why ratings and reviews are not published for every EHC Provider, and how this information can be helpful for our patients, please click here.
4.9 Provider showed concern 4.9 Provider explained things clearly 4.9 Provider discussed treatment options 4.9 Provider included you in decisions 4.9 Likelihood of recommending this provider